A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Asthma
Interventions
DRUG

Tofimilast

Trial Locations (22)

30281

Pfizer Investigational Site, Atlanta

32720

Pfizer Investigational Site, DeLand

37203

Pfizer Investigational Site, Nashville

37660

Pfizer Investigational Site, Kingsport

42431

Pfizer Investigational Site, Madisonville

45241

Pfizer Investigational Site, Cincinnati

53792

Pfizer Investigational Site, Madison

55402

Pfizer Investigational Site, Minneapolis

61761

Pfizer Investigational Site, Normal

75231

Pfizer Investigational Site, Dallas

92024

Pfizer Investigational Site, Encinitas

92506

Pfizer Investigational Site, Riverside

201301

Pfizer Investigational Site, Noida

632002

Pfizer Investigational Site, Vellore

02747

Pfizer Investigational Site, North Dartmouth

01107

Pfizer Investigational Site, Springfield

08558

Pfizer Investigational Site, Skillman

02865

Pfizer Investigational Site, Lincoln

Unknown

Pfizer Investigational Site, Barrio Aranjuez

Pfizer Investigational Site, San José

400 014

Pfizer Investigational Site, Mumbai

600 034

Pfizer Investigational Site, Chennai

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY